• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度脂蛋白与心血管疾病:致病和保护机制。

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.

机构信息

Department of Medicine, David Geffen School of Medicine, UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679, USA.

出版信息

Nat Rev Cardiol. 2011 Apr;8(4):222-32. doi: 10.1038/nrcardio.2010.222. Epub 2011 Feb 8.

DOI:10.1038/nrcardio.2010.222
PMID:21304474
Abstract

The lipoprotein HDL has two important roles: first, it promotes reverse cholesterol transport, and second, it modulates inflammation. Epidemiological studies show that HDL-cholesterol levels are inversely correlated with the risk of cardiovascular events. However, many patients who experience a clinical event have normal, or even high, levels of HDL cholesterol. Measuring HDL-cholesterol levels provides information about the size of the HDL pool, but does not predict HDL composition or function. The main component of HDL, apolipoprotein A-I (apo A-I), is largely responsible for reverse cholesterol transport through the macrophage ATP-binding cassette transporter ABCA1. Apo A-I can be damaged by oxidative mechanisms, which render the protein less able to promote cholesterol efflux. HDL also contains a number of other proteins that are affected by the oxidative environment of the acute-phase response. Modification of the protein components of HDL can convert it from an anti-inflammatory to a proinflammatory particle. Small peptides that mimic some of the properties of apo A-I have been shown in preclinical models to improve HDL function and reduce atherosclerosis without altering HDL-cholesterol levels. Robust assays to evaluate the function of HDL are needed to supplement the measurement of HDL-cholesterol levels in the clinic.

摘要

高密度脂蛋白(HDL)在脂蛋白中有两个重要作用:一是促进胆固醇逆向转运,二是调节炎症。流行病学研究表明,HDL 胆固醇水平与心血管事件的风险呈负相关。然而,许多经历临床事件的患者的 HDL 胆固醇水平正常,甚至偏高。测量 HDL 胆固醇水平可提供有关 HDL 池大小的信息,但不能预测 HDL 的组成或功能。HDL 的主要成分载脂蛋白 A-I(apo A-I)在很大程度上通过巨噬细胞三磷酸腺苷结合盒转运体 ABCA1 负责胆固醇的逆向转运。apo A-I 可被氧化机制破坏,使其更难以促进胆固醇外流。HDL 还含有许多其他受急性期反应氧化环境影响的蛋白质。HDL 蛋白成分的修饰可将其从抗炎颗粒转化为促炎颗粒。在临床前模型中,模拟 apo A-I 某些特性的小肽已被证明可改善 HDL 功能并减少动脉粥样硬化,而不会改变 HDL 胆固醇水平。需要功能齐全的 HDL 检测方法来补充临床中 HDL 胆固醇水平的测量。

相似文献

1
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.高密度脂蛋白与心血管疾病:致病和保护机制。
Nat Rev Cardiol. 2011 Apr;8(4):222-32. doi: 10.1038/nrcardio.2010.222. Epub 2011 Feb 8.
2
Inflammation, high density lipoprotein and endothelium.炎症、高密度脂蛋白与内皮
Curr Med Chem. 2014;21(25):2902-9. doi: 10.2174/0929867321666140414105530.
3
The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.高密度脂蛋白的双重性质:抗炎和促炎。
Biofactors. 2015 May 6;41(3):153-9. doi: 10.1002/biof.1205. Epub 2015 Jun 13.
4
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.高密度脂蛋白颗粒大小是 ABCA1 介导的巨噬细胞细胞胆固醇流出的关键决定因素。
Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14.
5
Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.新型载脂蛋白E衍生的ABCA1激动剂肽(CS-6253)在体外促进胆固醇逆向转运并诱导前β-1高密度脂蛋白的形成。
PLoS One. 2015 Jul 24;10(7):e0131997. doi: 10.1371/journal.pone.0131997. eCollection 2015.
6
Mechanisms of disease: proatherogenic HDL--an evolving field.疾病机制:促动脉粥样硬化性高密度脂蛋白——一个不断发展的领域。
Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):504-11. doi: 10.1038/ncpendmet0245.
7
High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases.高密度脂蛋白类似物:动脉粥样硬化疾病的治疗工具。
J Atheroscler Thromb. 2016;23(4):385-94. doi: 10.5551/jat.33720. Epub 2016 Feb 1.
8
Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.与年龄相关的高密度脂蛋白介导的逆向胆固醇转运活性降低。
Rejuvenation Res. 2009 Apr;12(2):117-26. doi: 10.1089/rej.2009.0840.
9
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.针对残余心血管风险:提高高密度脂蛋白胆固醇水平。
Postgrad Med J. 2008 Nov;84(997):590-8. doi: 10.1136/hrt.2007.125401.
10
Apolipoprotein A-II, HDL metabolism and atherosclerosis.载脂蛋白A-II、高密度脂蛋白代谢与动脉粥样硬化
Atherosclerosis. 2002 Sep;164(1):1-13. doi: 10.1016/s0021-9150(01)00751-1.

引用本文的文献

1
HDL-C/LDL-C Ratio and All-Cause Mortality in Populations at High CVD Risk: A Prospective Observational Cohort Study.高心血管疾病风险人群中高密度脂蛋白胆固醇/低密度脂蛋白胆固醇比值与全因死亡率:一项前瞻性观察队列研究
Chronic Dis Transl Med. 2025 Jul 21;11(3):213-223. doi: 10.1002/cdt3.70013. eCollection 2025 Sep.
2
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
3
From Hypothyroidism to Coronary Heart Disease: Unraveling the Lipid Profile Link: A Mendelian Randomization Study.

本文引用的文献

1
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.4F 肽可减少动脉粥样硬化的形成,并在载脂蛋白 E 基因敲除小鼠中诱导天然抗体产生。
FASEB J. 2011 Jan;25(1):290-300. doi: 10.1096/fj.10-165670. Epub 2010 Sep 27.
2
Revitalizing membrane rafts: new tools and insights.振兴膜筏:新工具和新见解。
Nat Rev Mol Cell Biol. 2010 Oct;11(10):688-99. doi: 10.1038/nrm2977.
3
Cell cholesterol homeostasis: mediation by active cholesterol.细胞胆固醇动态平衡:活性胆固醇的介导作用。
从甲状腺功能减退到冠心病:揭示血脂谱关联:一项孟德尔随机化研究
J Endocr Soc. 2025 Jun 23;9(9):bvaf108. doi: 10.1210/jendso/bvaf108. eCollection 2025 Sep.
4
High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels.高密度脂蛋白,第1部分。流行病学、抗动脉粥样硬化作用以及旨在提高其血清水平的治疗方法。
Am J Prev Cardiol. 2025 Jul 21;23:101068. doi: 10.1016/j.ajpc.2025.101068. eCollection 2025 Sep.
5
HDL cholesterol as a mediator of the relationship between breastfeeding and coronary atherosclerosis from a two-step Mendelian randomization analysis.基于两步孟德尔随机化分析的高密度脂蛋白胆固醇作为母乳喂养与冠状动脉粥样硬化关系的中介因素
Sci Rep. 2025 Aug 6;15(1):28739. doi: 10.1038/s41598-025-12369-w.
6
Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus.呼吸道病毒感染中的代谢重编程:聚焦于严重急性呼吸综合征冠状病毒2、流感病毒和呼吸道合胞病毒
Biomolecules. 2025 Jul 16;15(7):1027. doi: 10.3390/biom15071027.
7
Niacin and Stroke: The Role of Supplementation and Emerging Concepts in Clinical Practice, a Narrative Review.烟酸与中风:补充治疗的作用及临床实践中的新观念,一篇叙述性综述
Curr Issues Mol Biol. 2025 May 28;47(6):400. doi: 10.3390/cimb47060400.
8
Associations between non-traditional lipid parameters and normoglycemic reversion in Chinese adults with prediabetes: a retrospective analysis.中国成人糖尿病前期患者非传统血脂参数与血糖正常逆转之间的关联:一项回顾性分析
Front Endocrinol (Lausanne). 2025 Jun 24;16:1502861. doi: 10.3389/fendo.2025.1502861. eCollection 2025.
9
Apolipoprotein A1 Levels Are Inversely Associated with Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysms.载脂蛋白A1水平与未破裂颅内动脉瘤的瘤壁强化呈负相关。
Neurol Med Chir (Tokyo). 2025 Aug 15;65(8):340-347. doi: 10.2176/jns-nmc.2024-0258. Epub 2025 Jun 13.
10
Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals: The Framingham Heart Study.社区居住个体的血脂蛋白水平与阿尔茨海默病发病的关联:弗雷明汉心脏研究
Neurology. 2025 Jun 24;104(12):e213715. doi: 10.1212/WNL.0000000000213715. Epub 2025 May 30.
Trends Cell Biol. 2010 Nov;20(11):680-7. doi: 10.1016/j.tcb.2010.08.007. Epub 2010 Sep 16.
4
Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.载脂蛋白 A-I 模拟肽可预防糖尿病小鼠动脉粥样硬化的发展并减少斑块炎症。
Diabetes. 2010 Dec;59(12):3223-8. doi: 10.2337/db10-0844. Epub 2010 Sep 8.
5
The scavenger receptor class B, type I is a primary determinant of paraoxonase-1 association with high-density lipoproteins.清道夫受体 B 类,亚型 I 是对氧磷酶-1 与高密度脂蛋白结合的主要决定因素。
Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2121-7. doi: 10.1161/ATVBAHA.110.209122. Epub 2010 Aug 19.
6
Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report.载脂蛋白 G1 缺乏症小鼠动脉粥样硬化增加——简短报告。
Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2103-5. doi: 10.1161/ATVBAHA.110.212985. Epub 2010 Aug 12.
7
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).他汀类药物治疗后胆固醇酯转移蛋白质量与复发性冠状动脉事件风险(来自普伐他汀或阿托伐他汀评估与感染治疗-心肌梗死溶栓 22 试验[PROVE IT-TIMI 22 研究])。
Am J Cardiol. 2010 Aug 15;106(4):451-6. doi: 10.1016/j.amjcard.2010.03.057.
8
Congruency between biophysical data from multiple platforms and molecular dynamics simulation of the double-super helix model of nascent high-density lipoprotein.多平台生物物理数据与新生高密度脂蛋白双超螺旋模型分子动力学模拟的一致性。
Biochemistry. 2010 Aug 31;49(34):7323-43. doi: 10.1021/bi100588a.
9
Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution.载脂蛋白(Apo)A-I 结构对新生高密度脂蛋白(HDL)颗粒大小分布的影响。
J Biol Chem. 2010 Oct 15;285(42):31965-73. doi: 10.1074/jbc.M110.126292. Epub 2010 Aug 2.
10
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.L-4F可不同程度地改变血浆中氧化脂肪酸的水平,从而在小鼠体内产生更多具有抗炎作用的高密度脂蛋白。
Drug Metab Lett. 2010 Aug;4(3):139-48. doi: 10.2174/187231210791698438.